UnknownPhase 4NCT04852185
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International Vaccine Institute
- Principal Investigator
- Florian Marks, PhD, LMFT, LPCCUniversity of Cambridge
- Intervention
- Vi-TT(biological)
- Enrollment
- 23000 target
- Eligibility
- 15 years · All sexes
- Timeline
- 2021 – 2024
Study locations (1)
- Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, Ghana
Collaborators
Kwame Nkrumah University of Science and Technology · University of Cambridge · International Centre for Diarrhoeal Disease Research, Bangladesh · Fondation Mérieux · University of Maryland, Baltimore
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04852185 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950Induction of Gut Permeability by an Oral VaccineUSDA, Western Human Nutrition Research Center
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore